John G. Roberts

Preclinical Profile of a Potent γ-Secretase Inhibitor Targeting Notch Signaling with <i>In vivo</i> Efficacy and Pharmacodynamic Properties

Leopoldo Luistro, Wei He, Melissa Smith et al. · Cancer Research · 2009 · 191 citations · Full text

Medicine, Oncology, Pharmacology +16

Pharmacokinetics and tolerability of <scp>SRT</scp>2104, a first‐in‐class small molecule activator of <scp>SIRT</scp>1, after single and repeated oral administration in man

Ethan Hoffmann, J. Wald, Siva Lavu et al. · British Journal of Clinical Pharmacology · 2012 · 126 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +13

Oral Advocacy and the Re-emergence of a Supreme Court Bar

John G. Roberts · Journal of Supreme Court History · 2005 · 77 citations

Law, Constitutional Law, Public Law +15

Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF‐1 suppression to octreotide LAR in healthy volunteers

Fredrik Tiberg, John G. Roberts, Camilla Cervin et al. · British Journal of Clinical Pharmacology · 2015 · 71 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Sulfonamides as Selective Na_V1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity

Russell F. Graceffa, Alessandro A. Boezio, Jessica Able et al. · Journal of Medicinal Chemistry · 2017 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15